Table 1. Demographics and Clinical Characteristics of Patients With NAFLD and Controlsa.
| Characteristics | NAFLD Patients (n = 184) | Controls (n = 114) | P Value |
|---|---|---|---|
| Height, cm | 167.72 ± 8.23 | 165.96 ± 6.44 | .053 |
| Weight, kg | 74.29 ± 11.34 | 63.55 ± 10.88 | .000 |
| BMI, kg/m 2 | 26.34 ± 3.05 | 23.04 ± 3.47 | .000 |
| Waist circumference, cm | 92.36 ± 9.17 | 82.28 ± 8.79 | .000 |
| Hip circumference, cm | 102.91 ± 8.22 | 96.92 ± 9.13 | .000 |
| ALT, U/L | 25.43 ± 14.17 | 19.39 ± 10.14 | .000 |
| AST, U/L | 21.91 ± 11.11 | 19.48 ± 6.34 | .034 |
| GGT, U/L | 21.35 ± 8.613 | 14.96 ± 5.731 | .000 |
| Glu, mmol/L | 5.60 ± 1.88 | 5.01 ± 1.24 | .003 |
| TG, mmol/L | 1.76 ± 0.95 | 1.13 ± 0.67 | .000 |
| TC, mmol/L | 4.90 ± 0.96 | 4.63 ± 0.93 | .018 |
| HDL, mmol/L | 1.29 ± 0.48 | 1.47 ± 0.33 | .000 |
| LDL, mmol/L | 3.29 ± 0.93 | 2.93 ± 0.81 | .001 |
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; GGT, gamma-glutamyl transpeptidase; Glu, glucose; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NAFLD, non-alcoholic fatty liver disease patients; TC, total cholesterol; TG, triglyceride.
aData are presented as mean ± SD.